siRNA treatment decreases triglycerides in people with rare health condition

.ANALYSIS FEATURE.19 September 2024.

Plozasiran decreased triglyceride levels by 80% and also reduced the risk of pancreatitis in individuals along with persistent chylomicronemia, along with or even without a genetic diagnosis.